The Friday Report is our regular update (currently monthly) with a summary of the key papers and analyses that we’ve looked at recently. In Friday Report 68 we report on:
- FDA authorisation of vaccines for children
- Omicron-specific vaccine – Moderna’s successful trials
- Prevalence of sub-variants
- Variant-specific symptoms of COVID-19
- Immune boosting by Omicron – effect of SARS-CoV-2 exposure
- Clinical outcomes for Omicron vs Delta
- Neurodevelopmental problems following exposure to COVID whilst in the womb
- Effectiveness of Evushield during the US Omicron surge
- Risk of Long COVID – Delta vs Omicron
- Higher IFRs shown in less developed countries
- Outcomes of SARS-CoV-2 reinfection
- UK stats on infectivity and hospital admissions
And finally – a new way to detect COVID-19 that may sound barking mad …